AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Pieniaszek, HJ
Citation: Hj. Pieniaszek, Products approved in the United States for marketing during 2000, J CLIN PHAR, 41(5), 2001, pp. 479-481

Authors: Joshi, AS Pieniaszek, HJ Vokes, EE Vogelzang, NJ Davidson, AF Richards, LE Chai, MF Finizio, M Ratain, MJ
Citation: As. Joshi et al., Elimination pathways of [C-14]losoxantrone in four cancer patients, DRUG META D, 29(2), 2001, pp. 96-99

Authors: Barrett, JS Hainer, JW Kornhauser, DM Gaskill, JL Hua, TA Sprogel, P Johansen, K van Lier, JJ Knebel, W Pieniaszek, HJ
Citation: Js. Barrett et al., Anticoagulant pharmacodynamics of tinzaparin following 175 IU/kg subcutaneous administration to healthy volunteers, THROMB RES, 101(4), 2001, pp. 243-254

Authors: Barrett, JS Yu, J Kapil, R Padovani, P Brown, F Ebling, WF Corjay, MH Reilly, TM Bozarth, JM Mousa, SA Pieniaszek, HJ
Citation: Js. Barrett et al., Disposition and exposure of the fibrinogen receptor antagonist XV459 on alpha(IIB)beta(3), binding sites in the guinea pig, BIOPHARM DR, 20(6), 1999, pp. 309-318

Authors: Pieniaszek, HJ Mayersohn, M Adams, MP Reinhart, RJ Barrett, JS
Citation: Hj. Pieniaszek et al., Moricizine bioavailability via simultaneous, dual, stable isotope administration: Bioequivalence implications, J CLIN PHAR, 39(8), 1999, pp. 817-825

Authors: Pieniaszek, HJ Davidson, AF Chaney, JE Shum, L Robinson, CA Mayersohn, M
Citation: Hj. Pieniaszek et al., Human moricizine metabolism. II. Quantification and pharmacokinetics of plasma and urinary metabolites, XENOBIOTICA, 29(9), 1999, pp. 945-955

Authors: Richards, LE Pieniaszek, HJ Shatzmiller, S Page, GO Blom, KF Read, JM Davidson, AF Confalone, PN
Citation: Le. Richards et al., Human moricizine metabolism. I. Isolation and identification of metabolites in human urine (vol 27, pg 217, 1997), XENOBIOTICA, 29(9), 1999, pp. 969-969
Risultati: 1-7 |